Cleveland Clinic study shows bariatric surgery outperforms GLP-1 diabetes drugs for kidney protection

Bariatric surgery was shown to protect kidney function and reduce the risk of kidney failure in study participants when compared to GLP-1 medications

2024-09-20

(Press-News.org) Cleveland Clinic Study Shows Bariatric Surgery Outperforms GLP-1 Diabetes Drugs for Kidney Protection

Bariatric surgery was shown to protect kidney function and reduce the risk of kidney failure in study participants when compared to GLP-1 medications

Friday, September 20, 2024, CLEVELAND: A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals of Surgery.

According to the Centers for Disease Control and Prevention, more than 1 in 7 U.S. adults are estimated to have chronic kidney disease, which can lead to renal failure. Chronic kidney disease is the longstanding disease of the kidneys which can lead to renal failure. Kidneys filter waste through the blood. As kidneys begin to fail, that waste can build up. Some patients need dialysis, which filters the blood through a machine.

Ali Aminian, M.D., lead author of the study and director of Cleveland Clinic’s Bariatric & Metabolic Institute, said, “Our study shows that bariatric surgery can protect the kidneys and prevent the worsening of kidney function. In patients with obesity and type 2 diabetes who already have established chronic kidney disease, bariatric surgery can change the trajectory of the disease.”

The study included 425 adult patients (ages 18 to 75) with type 2 diabetes, obesity, and stage 3 or 4 chronic kidney disease. Among the study participants, 183 patients underwent bariatric surgery while 242 patients were treated with GLP-1 receptor agonist medications.

Patients involved in the study underwent bariatric surgery between 2010 and 2017 or continuously received GLP-1 medications that were FDA-approved and available during the timeframe of the study. In the nonsurgical group, the most common GLP-1 medications were liraglutide and exenatide. During follow-up, 20% of patients in the nonsurgical group received newer GLP-1 medications such as semaglutide (Ozempic) or tirzepatide (Mounjaro) at some point.

Researchers found that bariatric surgery could protect kidney function and reduce the risk of kidney failure or death in patients. Specifically, study findings showed that bariatric surgery was associated with a 60% lower risk of progression of kidney disease and a 44% lower risk of developing kidney failure or death in comparison to the nonsurgical group.

Over the length of the eight-year study, researchers also found that 22% of the participants in the surgical group experienced progression of kidney disease compared to 45% in the non-surgical group. In addition, 24% in the surgical group developed kidney failure or died over the seven-year span of the study, compared to 44% in the non-surgical group.

The study participants who underwent bariatric surgery experienced more weight loss and better control of their diabetes. They also required less medication to control their diabetes, high blood pressure and high cholesterol.

“Despite its kidney-protective benefits, bariatric surgery is underutilized in clinical practice,” said Dr. Aminian. “In the current management guidelines of chronic kidney disease, while maintaining a healthy weight through lifestyle changes is advised, the option of bariatric surgery has not been considered.”

Jonathan Taliercio, D.O., a nephrologist at Cleveland Clinic and co-author of the study, added: “These numbers are promising and show bariatric surgery should be considered as a treatment option for patients with chronic kidney disease and obesity.”

Dr. Aminian said that GLP-1 receptor agonist medications are quickly evolving, and the role they have in combination with bariatric surgery needs further investigation.

About Cleveland Clinic

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. Cleveland Clinic is consistently recognized in the U.S. and throughout the world for its expertise and care. Among Cleveland Clinic’s 81,000 employees worldwide are more than 5,743 salaried physicians and researchers, and 20,160 registered nurses and advanced practice providers, representing 140 medical specialties and subspecialties. Cleveland Clinic is a 6,690-bed health system that includes a 173-acre main campus near downtown Cleveland, 23 hospitals, 276 outpatient facilities, including locations in northeast Ohio; Florida; Las Vegas, Nevada; Toronto, Canada; Abu Dhabi, UAE; and London, England. In 2023, there were 13.7 million outpatient encounters, 323,000 hospital admissions and observations, and 301,000 surgeries and procedures throughout Cleveland Clinic’s health system. Patients came for treatment from every state and 132 countries. Visit us at clevelandclinic.org. Follow us at twitter.com/CleClinicNews. News and resources available at newsroom.clevelandclinic.org.

Editor’s Note: Cleveland Clinic News Service is available to provide broadcast-quality interviews and B-roll upon request.

END

ELSE PRESS RELEASES FROM THIS DATE:

Study reveals large ocean heat storage efficiency during the last deglaciation

2024-09-20

As one of the largest heat reservoirs in the climate system, the global ocean absorbs more than 90% of the excess energy from ongoing anthropogenic warming. In the last century, the greatest warming in the ocean has occurred in the upper 500 m, with relatively weak warming in the deep ocean, corresponding to a small ocean heat storage efficiency of ~0.1. Paleoceanographic observations, however, suggest that on long time scales, the deep ocean warming can be comparable to or larger than the surface ocean warming, with ocean heat storage efficiency during the last ...

Fever drives enhanced activity, mitochondrial damage in immune cells

2024-09-20

Fever temperatures rev up immune cell metabolism, proliferation and activity, but they also — in a particular subset of T cells — cause mitochondrial stress, DNA damage and cell death, Vanderbilt University Medical Center researchers have discovered. The findings, published Sept. 20 in the journal Science Immunology, offer a mechanistic understanding for how cells respond to heat and could explain how chronic inflammation contributes to the development of cancer. The impact of ...

A two-dose schedule could make HIV vaccines more effective

2024-09-20

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, allowing it to evade the antibody response generated by vaccines. Several years ago, MIT researchers showed that administering a series of escalating doses of an HIV vaccine over a two-week period could help overcome a part of that challenge by generating larger quantities of neutralizing antibodies. However, a multidose vaccine regimen administered over a short time is not practical for mass vaccination campaigns. In a new study, the researchers have now found that they ...

Wastewater monitoring can detect foodborne illness, researchers find

2024-09-20

UNIVERSITY PARK, Pa. — First used in the 1940s to monitor for polio, wastewater surveillance proved such a powerful disease monitoring tool that the U.S. Centers for Disease Control and Prevention (CDC) established the National Wastewater Surveillance System to support SARS-CoV-2 monitoring in September of 2020. Now, a team of scientists from Penn State and the Pennsylvania Department of Health have shown that domestic sewage monitoring is useful for a foodborne pathogen as well. In findings published today (Sept. 19) in the Journal of Clinical ...

Kowalski, Salonvaara receive ASHRAE Distinguished Service Awards

2024-09-20

Building equipment and envelope scientists at the Department of Energy’s Oak Ridge National Laboratory were recognized for research excellence during the ASHRAE 2024 summer conference held in Indianapolis. Stephen Kowalski and Mikael Salonvaara received the Distinguished Service Award, which salutes members who have served the society with distinction in chapter, regional and society activities. Kowalski and Salonvaara have each been active members of ASHRAE for more than 25 years and have supported the organization’s Technical and Standards Project Committees. ASHRAE is the largest international professional organization ...

SkAI launched to further explore universe

2024-09-20

Funded by a five-year, $20 million grant from the U.S. National Science Foundation (NSF) and the Simons Foundation, the National Center for Supercomputing Applications is partnering with other academic institutions and federal laboratories in the Midwest to develop new artificial intelligence (AI) tools to advance astrophysics research and exploration of the universe. Led by Northwestern University, the collaboration will establish the NSF-Simons AI Institute for the Sky or SkAI (pronounced “sky”), one of two AI research centers that will help astronomers better understand the cosmos. Located close to NCSA’s home in Illinois, SkAI will ...

SLU researchers identify sex-based differences in immune responses against tumors

2024-09-20

ST. LOUIS — Researchers at Saint Louis University School of Medicine investigated differences in T-cell responses between male and female patients with lung cancer that may help direct future treatments. T-cell responses are part of the adaptive immune system, part of the body’s “smart system” that monitors for threats and fights them with customized defenses. "Therapies that use the patient's immune system to fight their disease have a lot of potential to ...

Evolved in the lab, found in nature: uncovering hidden pH sensing abilities

2024-09-20

By Andy Flick, Evolutionary Studies scientific coordinator In a groundbreaking study led by Sarah Worthan, Ph.D., a postdoctoral researcher in the Behringer Lab at Vanderbilt University, scientists have successfully evolved microbial cultures that possess the ability to sense pH changes, enabling rapid responses to environmental fluctuations. Along with highlighting the power of lab-driven evolution, this discovery also led to finding similar mutations in nature in emerging pathogens and coral symbionts—organisms that navigate challenging pH shifts in their environments and are ...

Unlocking the potential of patient-derived organoids for personalized sarcoma treatment

2024-09-20

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to work for each individual patient. The approach, detailed in the journal Cell Stem Cell, uses patients’ own tumor cells that replicate the unique characteristics of a patient's tumor allowing scientists to quickly screen a large number of drugs in order to identify personalized treatments that can target this rare and diverse group of cancers. “Sarcoma is a rare and complex disease, which makes conducting clinical trials ...

New drug molecule could lead to new treatments for Parkinson’s disease in younger patients

2024-09-20

A novel drug molecule could potentially lead to new treatments to prevent Parkinson’s disease in younger patients, according to new research. “We are excited about this drug compound because we might have the possibility to develop the first cure for Parkinson’s disease, at least for a subset of patients,” said lead author Kalle Gehring, a Professor in the Department of Biochemistry at McGill University and Canada Research Chair in Structural Studies of Neurodegenerative Diseases. While Parkinson’s symptoms — slowed movements, tremors and balance problems — often appear in ...

LAST 30 PRESS RELEASES:

UAB startup Endomimetics receives $2.8 million Small Business Innovation Research grant

Scientists turn to human skeletons to explore origins of horseback riding

UCF receives prestigious Keck Foundation Award to advance spintronics technology